A detailed history of Capula Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Capula Management LTD holds 1,800 shares of ABT stock, worth $205,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,800
Previous 3,200 43.75%
Holding current value
$205,614
Previous $332,000 38.25%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $290,002 - $342,340
2,898 Added 380.81%
3,659 $417,000
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $143,137 - $159,777
-1,421 Reduced 65.12%
761 $79,000
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $238,972 - $263,934
2,182 New
2,182 $248,000
Q3 2023

Nov 03, 2023

BUY
$95.53 - $114.62 $203,478 - $244,140
2,130 New
2,130 $206,000
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $5.67 Million - $6.68 Million
58,561 New
58,561 $5.93 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $5.3 Million - $6.14 Million
54,809 New
54,809 $5.3 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $2.78 Million - $3.41 Million
-24,096 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $2.15 Million - $2.37 Million
18,396 Added 322.74%
24,096 $2.84 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $603,003 - $709,821
5,700 New
5,700 $658,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $2.37 Million - $3.03 Million
-30,958 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $1.94 Million - $2.84 Million
30,958 New
30,958 $2.44 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.